In line with their findings, our previous studies have discovered that continuous low-dose THC intranasal treatment exhibited multiple effects on AD-related pathological changes, including the inhibition of Aβ production and aggregation, a reduction in tau hyperphosphorylation and enhancement of mitochondrial function [24,25]. Here, MAPT is linked to Alzheimer disease.